Literature DB >> 20224973

Derivation, culture, and characterization of VUB hESC lines.

Ileana Mateizel1, Claudia Spits, Martine De Rycke, Inge Liebaers, Karen Sermon.   

Abstract

In this report, we present the derivation and characterization of 15 hESC lines established at the Vrije Universiteit Brussel, Belgium in collaboration with the Universitair Ziekenhuis Brussel, Belgium, using surplus in vitro fertilization embryos and embryos carrying monogenic disorders donated for research. Four lines were derived from blastocyst-stage embryos presumed to be genetically normal, and 11 hESC lines were obtained from embryos shown to carry genetic mutations by preimplantation genetic diagnosis. All the lines express markers of pluripotency as determined by immunocytochemistry and RT-PCR, and formed teratomas when injected into SCID mice. All VUB hESC lines, except for VUB17, are reported in the European hESC registry and are available upon request after signing a Material Transfer Agreement from the VUB (contact person: Prof. Dr. Karen Sermon; Karen.Sermon@uzbrussel.be).

Entities:  

Mesh:

Year:  2010        PMID: 20224973     DOI: 10.1007/s11626-010-9284-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  14 in total

Review 1.  Preimplantation genetic diagnosis.

Authors:  Karen Sermon; André Van Steirteghem; Inge Liebaers
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

Review 2.  Repeat instability: mechanisms of dynamic mutations.

Authors:  Christopher E Pearson; Kerrie Nichol Edamura; John D Cleary
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

3.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

Review 4.  PGD for monogenic disorders: aspects of molecular biology.

Authors:  Claudia Spits; Karen Sermon
Journal:  Prenat Diagn       Date:  2009-01       Impact factor: 3.050

5.  Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease.

Authors:  Asa Abeliovich; Claudia A Doege
Journal:  Neuron       Date:  2009-02-12       Impact factor: 17.173

Review 6.  iPS cells: a more critical review.

Authors:  Shi V Liu
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

7.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

8.  Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

Authors:  I Mateizel; N De Temmerman; U Ullmann; G Cauffman; K Sermon; H Van de Velde; M De Rycke; E Degreef; P Devroey; I Liebaers; A Van Steirteghem
Journal:  Hum Reprod       Date:  2005-11-10       Impact factor: 6.918

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation.

Authors:  N De Temmerman; S Seneca; A Van Steirteghem; P Haentjens; J Van der Elst; I Liebaers; K D Sermon
Journal:  Mol Hum Reprod       Date:  2008-06-24       Impact factor: 4.025

View more
  12 in total

1.  Sertoli cell-conditioned medium induces germ cell differentiation in human embryonic stem cells.

Authors:  Mieke Geens; Karen Dora Sermon; Hilde Van de Velde; Herman Tournaye
Journal:  J Assist Reprod Genet       Date:  2011-02-12       Impact factor: 3.412

2.  Female sex bias in human embryonic stem cell lines.

Authors:  Dalit Ben-Yosef; Ami Amit; Mira Malcov; Tsvia Frumkin; Ahmi Ben-Yehudah; Ido Eldar; Nava Mey-Raz; Foad Azem; Gheona Altarescu; Paul Renbaum; Rachel Beeri; Irit Varshaver; Talia Eldar-Geva; Silvina Epsztejn-Litman; Ephrat Levy-Lahad; Rachel Eiges
Journal:  Stem Cells Dev       Date:  2011-06-24       Impact factor: 3.272

3.  Modelling familial dysautonomia in human induced pluripotent stem cells.

Authors:  Gabsang Lee; Lorenz Studer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

Review 4.  Modelling human disease with pluripotent stem cells.

Authors:  Richard Siller; Sebastian Greenhough; In-Hyun Park; Gareth J Sullivan
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

5.  A High Proliferation Rate is Critical for Reproducible and Standardized Embryoid Body Formation from Laminin-521-Based Human Pluripotent Stem Cell Cultures.

Authors:  Dominika Dziedzicka; Christina Markouli; Lise Barbé; Claudia Spits; Karen Sermon; Mieke Geens
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

6.  Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture.

Authors:  Nilendran Prathalingam; Linda Ferguson; Lesley Young; Georg Lietz; Rachel Oldershaw; Lyn Healy; Albert Craig; Helen Lister; Rakesh Binaykia; Radhika Sheth; Alison Murdoch; Mary Herbert
Journal:  Stem Cell Res Ther       Date:  2012-03-28       Impact factor: 6.832

7.  Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability.

Authors:  Kurt Jacobs; Filippo Zambelli; Afroditi Mertzanidou; Ilse Smolders; Mieke Geens; Ha Thi Nguyen; Lise Barbé; Karen Sermon; Claudia Spits
Journal:  Stem Cell Reports       Date:  2016-02-25       Impact factor: 7.765

8.  In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors.

Authors:  Suzanne Vanhauwaert; Bieke Decaesteker; Sara De Brouwer; Carina Leonelli; Kaat Durinck; Pieter Mestdagh; Jo Vandesompele; Karen Sermon; Geertrui Denecker; Christophe Van Neste; Frank Speleman; Katleen De Preter
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

Review 9.  Comparing ESC and iPSC-Based Models for Human Genetic Disorders.

Authors:  Tomer Halevy; Achia Urbach
Journal:  J Clin Med       Date:  2014-10-24       Impact factor: 4.241

Review 10.  Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells.

Authors:  Hagar Mor-Shaked; Rachel Eiges
Journal:  Genes (Basel)       Date:  2016-09-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.